As of 2025-06-24, the Relative Valuation of Esperion Therapeutics Inc (ESPR) is (13.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.04 USD, the upside of Esperion Therapeutics Inc based on Relative Valuation is -1354.4%.
The range of the Relative Valuation is (11.44) - (14.77) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 22.4x | 17.8x |
| Forward P/E multiples | 14.8x - 19.1x | 16.0x |
| Fair Price | (11.44) - (14.77) | (13.05) |
| Upside | -1200.1% - -1519.8% | -1354.4% |
| Date | P/E |
| 2025-06-23 | -1.35 |
| 2025-06-20 | -1.38 |
| 2025-06-18 | -1.42 |
| 2025-06-17 | -1.41 |
| 2025-06-16 | -1.51 |
| 2025-06-13 | -1.51 |
| 2025-06-12 | -1.55 |
| 2025-06-11 | -1.57 |
| 2025-06-10 | -1.58 |
| 2025-06-09 | -1.55 |
| 2025-06-06 | -1.58 |
| 2025-06-05 | -1.50 |
| 2025-06-04 | -1.45 |
| 2025-06-03 | -1.36 |
| 2025-06-02 | -1.19 |
| 2025-05-30 | -1.10 |
| 2025-05-29 | -1.13 |
| 2025-05-28 | -1.08 |
| 2025-05-27 | -1.06 |
| 2025-05-23 | -1.02 |
| 2025-05-22 | -1.04 |
| 2025-05-21 | -1.10 |
| 2025-05-20 | -1.18 |
| 2025-05-19 | -1.12 |
| 2025-05-16 | -1.04 |
| 2025-05-15 | -1.01 |
| 2025-05-14 | -0.94 |
| 2025-05-13 | -1.01 |
| 2025-05-12 | -1.03 |
| 2025-05-09 | -1.03 |
| 2025-05-08 | -1.15 |
| 2025-05-07 | -1.13 |
| 2025-05-06 | -1.26 |
| 2025-05-05 | -1.36 |
| 2025-05-02 | -1.41 |
| 2025-05-01 | -1.27 |
| 2025-04-30 | -1.29 |
| 2025-04-29 | -1.24 |
| 2025-04-28 | -1.17 |
| 2025-04-25 | -1.19 |
| 2025-04-24 | -1.14 |
| 2025-04-23 | -1.23 |
| 2025-04-22 | -1.20 |
| 2025-04-21 | -1.10 |
| 2025-04-17 | -1.23 |
| 2025-04-16 | -1.25 |
| 2025-04-15 | -1.29 |
| 2025-04-14 | -1.29 |
| 2025-04-11 | -1.32 |
| 2025-04-10 | -1.24 |